Construction and Testing of Two Distinct Humanized CD19-Specific Chimeric Antigen Receptors (CARs) for the Treatment of B-Cell Malignancies

被引：0
|
作者：
Gopalakrishnan, Ramakrishnan [1 ]
Matta, Hittu [1 ]
Choi, Sunju [2 ]
Han, Xu [2 ]
Prakash, Rekha [2 ]
Narasappa, Nell [2 ]
Gong, Songjie [2 ]
Chitnis, Saurabh [2 ]
Kahn, Michael [2 ]
Sernas, Jennifer [2 ]
Khan, Prottasha [2 ]
Chaudhary, Preet [2 ]
机构：
[1] Univ So Calif, Ctr Study Blood Dis, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Los Angeles, CA 90033 USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.4025.4025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4025
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    James N. Kochenderfer
    Steven A. Rosenberg
    Nature Reviews Clinical Oncology, 2013, 10 : 267 - 276
  • [32] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    Kochenderfer, James N.
    Rosenberg, Steven A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (05) : 267 - 276
  • [33] Adoptive T-cell therapy of B-cell malignancies: Conventional and physiological chimeric antigen receptors
    Liu, Lin
    Sun, Meili
    Wang, Zhehai
    CANCER LETTERS, 2012, 316 (01) : 1 - 5
  • [34] Quantitative single-cell functional characterization of CD19-specific chimeric antigen receptor T cells
    Varadarajan, Navin
    Liadi, Ivan
    Romain, Gabrielle
    Singh, Harjeet
    Cooper, Laurence
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [35] Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
    Zhitao Ying
    Ting He
    Xiaopei Wang
    Wen Zheng
    Ningjing Lin
    Meifeng Tu
    Yan Xie
    Lingyan Ping
    Chen Zhang
    Weiping Liu
    Lijuan Deng
    Meng Wu
    Feier Feng
    Xin Leng
    Tingting Du
    Feifei Qi
    Xuelian Hu
    Yanping Ding
    Xin-an Lu
    Yuqin Song
    Jun Zhu
    BMC Cancer, 21
  • [36] Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
    Ying, Zhitao
    He, Ting
    Wang, Xiaopei
    Zheng, Wen
    Lin, Ningjing
    Tu, Meifeng
    Xie, Yan
    Ping, Lingyan
    Zhang, Chen
    Liu, Weiping
    Deng, Lijuan
    Wu, Meng
    Feng, Feier
    Leng, Xin
    Du, Tingting
    Qi, Feifei
    Hu, Xuelian
    Ding, Yanping
    Lu, Xin-an
    Song, Yuqin
    Zhu, Jun
    BMC CANCER, 2021, 21 (01)
  • [37] Allogeneic NKT Cells Expressing a CD19-Specific CAR in Patients with Relapsed or Refractory B-Cell Malignancies: An Interim Analysis
    Ramos, Carlos A.
    Courtney, Amy N.
    Robinson, Simon N.
    Dakhova, Olga
    Lulla, Premal D.
    Kamble, Rammurti
    Carrum, George
    Wang, Tao
    Zhang, Chunchao
    Di Pierro, Erica
    Metelitsa, Leonid S.
    BLOOD, 2021, 138
  • [38] Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
    Sabatino, Marianna
    Hu, Jinhui
    Sommariva, Michele
    Gautam, Sanjivan
    Fellowes, Vicki
    Hocker, James D.
    Dougherty, Sean
    Qin, Haiying
    Klebanoff, Christopher A.
    Fry, Terry J.
    Gress, Ronald E.
    Kochenderfer, James N.
    Stroncek, David F.
    Ji, Yun
    Gattinoni, Luca
    BLOOD, 2016, 128 (04) : 519 - 528
  • [39] Chimeric Antigen Receptor Natural Killer Cells for the Treatment of Patients With B-Cell Malignancies
    Rezvani, Katy
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 543 - 545
  • [40] Cord blood-derived CD19-specific chimeric antigen receptor T cells: an off-the-shelf promising therapeutic option for treatment of diffuse large B-cell lymphoma
    Yu, Tiantian
    Luo, Cancan
    Zhang, Huihui
    Tan, Yi
    Yu, Li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345